866-997-4948(US-Canada Toll Free)

Pharmaceuticals for Womens Health: Global Markets to 2023

Published By :

BCC Research

Published Date : Jul 2018

Category :

Pharmaceutical

No. of Pages : 141 Pages

"Summay

Women's health therapeutics have a strong presence in the global pharmaceutical market, and that presence is expected to increase from approximately $x.x billion in 2017 to nearly $x.x billion by 2023, at a CAGR of x.x%. North America dominates the global womens health market, with a marketshare of x.x% in 2017. North America will continue with its leading position, followed by Europe and Asia-Pacific, during the forecast period.

The postmenopausal osteoporosis segment leads the global women's health therapeutics and technologies market and will continue to significantly drive market growth, followed by pregnancy disorders and management, menopause-related conditions, endometriosis and polycystic ovary syndrome. Pharmaceutical companies in the women's healthcare space are expanding their R&D base and doubling efforts to expand beyond reproductive health into key women's health areas, such as menopause-related conditions and osteoporosis. Existing therapies for these health problems have issues pertaining to safety and efficacy; for instance, hormone therapy comes with serious safety concerns. Therefore, there is growing unmet need for better and safer products, particularly from growing elderly populations. Osteoporosis, similar to hormone therapy, sees increasing demand due to a growing older demographic, but safety concerns have curbed efforts to address that demand. The bisphosphonate category, while regarded by physicians as safe and effective, has suffered considerably over concerns of atypical fractures and osteonecrosis of the jaw.

Women's health therapeutics have established a very strong presence in the global pharmaceutical market over the last few decades. The market is expected to grow moderately, mainly due to patent expirations of blockbuster drugs such as Evista, the Premarin family, Forteo, Mirena, Boniva, Actonel, Gonal-F and several others. However, the launch of new drugs in the market, and novel drugs under research and development in the late-stage pipeline, has the strong potential to drive the market during the forecast period.

The global womens health therapeutics market is dominated by Eli Lilly; Amgen, Inc.; Merck & Co, Inc.; AbbVie, Inc.; Bayer AG and Pfizer Inc. They held a significant share of the global womens health market in 2017. Tier 1 companies dominate the market share owing to increased preference of their product portfolio, revenue from their womens health portfolios, overall sales and the companys global presence."

"Report Scope

While womens health encompasses several health issues, this report will focus on menopause-related disorders, postmenopausal osteoporosis, endometriosis, polycystic ovarian syndrome and pregnancy disorders. This report does not focus on drugs for infertility, diagnostic and drug technologies for breast cancer or therapies and diagnostics for ovarian cancer. However, we have individuals reports which discusses the scope of these health concerns in detail. The report codes for these reports are listed below:

- PHM194A Drugs for Infertility: Global Markets.
- HLC143B Therapies and Diagnostics for Ovarian Cancer: Global Markets.
- HLC209A U.S. Fertility Clinics Market.
- HLC106B Breast Cancer Diagnostic and Drug Technologies: Global Markets.

Report Includes

- 26 data tables and 34 additional tables
- Detailed overview of the global markets for pharmaceuticals for women's health
- Country specific data and analysis for United States, Mexico, Germany, U.K., France, China, India, Japan, Middle East and Africa
- A look at the regulatory environment which has been a driving force in the drug development industry
- Information on competitor initiatives, and information with regard to demand for specialty chemicals used to develop new products and for new applications
- A relevant patent analysis within the sector
- Comprehensive company profiles of major Players in the Market including AbbVie Inc., Allergan PLC, Amgen Inc., Bayer Ag., Eli Lilly and Company, Johnson & Johnson Inc., Novo Nordisk and Pfizer Inc."
Table of Contents
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Technologies and Global Markets Overview
Disease Overview and Definitions
Market Driving Factors and Opportunities
Aging Female Population
Government Involvement and Increased Funding
Increasing Awareness Regarding Women's Disorders and Treatments
Market Restraints
Poor Diagnosis
Availability of Alternate Treatment Options and Lifestyle Changes
Unavailability of Novel Treatments
High Cost of Treatment
Chapter 4 Pipeline Assessment and Analysis
List of Drugs in Pipeline
Overview of Osteoporosis Drug Development Pipeline
Late-stage Pipeline Drugs
Elagolix (AbbVie Inc.)
Vilaprisan (Bayer AG)
Evenity (Amgen Inc.)
Relugolix (Myovant Sciences)
Proellex (Repros Therapeutics)
Esmya (Allergan Inc.)
TX-004HR (TherapeuticsMD, Inc.)
TX-001HR (TherapeuticsMD, Inc.)
Chapter 5 Regulatory Structure
Overview of Regulations
United States
Canada
Europe
Japan
Overview of Pricing and Reimbursement
United States
Canada
Europe
Japan
Chapter 6 Market Breakdown by Women's Health Disorders
Introduction
Menopause-Related Diseases
Overview
Symptoms
Risk Factors
Epidemiology and Economic Burden
Diagnosis
Treatments
Market Size and Forecasts
Postmenopausal Osteoporosis
Overview
Epidemiology and Economic Burden
Diagnosis
Treatments
Market Size and Forecasts
Endometriosis
Overview
Epidemiology and Economic Burden
Diagnosis
Treatments
Market Size and Forecasts
Polycystic Ovary Syndrome (PCOS)
Overview
Reducing the Risk of PCOS
Epidemiology and Economic Burden
Diagnosis
Treatments
Market Size and Forecasts
Pregnancy Disorders and Management
Overview
Market Size and Forecasts
Others
Overview
Market Size and Forecasts
Chapter 7 Market Breakdown by Region
Introduction
North America
United States
Canada
Mexico
Europe
United Kingdom
Germany
France
Spain
Italy
Rest of Europe
Asia-Pacific
China
Japan
India
South Korea
Rest of Asia-Pacific
South America
Middle East and Africa
Chapter 8 Competitive Landscape and Key Developments
Market Players and Strategy
Patent Analysis
List of Key Patents
Key Developments
Mergers and Acquisitions
Development of Innovative Products/Novel Product Launch
Agreements, Collaborations & Partnerships
Key Products
Chapter 9 Company Profiles
ABBVIE INC.
Company Overview
Product Information
Development and Strategies
Financials
ALLERGAN PLC.
Company Overview
Product Information
Development and Strategies
Financials
AMGEN INC.
Company Overview
Product Information
Development and Strategies
Financials
BAYER AG
Company Overview
Product Information
Development and Strategies
Financials
DAIICHI SANKYO COMPANY. LTD.
Company Overview
Product Information
Development and Strategies
Financials
ELI LILLY AND COMPANY
Company Overview
Product Information
Development and Strategies
Financials
JOHNSON & JOHNSON INC.
Company Overview
Product Information
Financials
MERCK & CO. INC.
Company Overview
Product Information
Development and Strategies
Financials
MERCK KGAA
Company Overview
Product Information
NOVO NORDISK
Company Overview
Product Information
Financials
PFIZER INC.
Company Overview
Product Information
Development and Strategies
Financials
Chapter 10 Appendix
Abbreviations Used in the Report

List of Table

List of Tables
Summary Table : Global Market for Women's Health Therapeutics, by Disease Area, Through 2023
Table 1 : Life Expectancy at Birth, Both Sexes Combined, by Region
Table 2 : Pipeline Molecules, Endometriosis
Table 3 : Pipeline Molecules, Uterine Fibroids
Table 4 : Pipeline Molecules, All Other Indications
Table 5 : Pipeline Molecules, Osteoporosis
Table 6 : Elagolix Snapshot
Table 7 : Vilaprisan Snapshot
Table 8 : Evenity Snapshot
Table 9 : Relugolix Snapshot
Table 10 : Proellex Snapshot
Table 11 : Esmya Snapshot
Table 12 : TX-004HR Snapshot
Table 13 : TX-001HR Snapshot
Table 14 : Global Market for Womens Health Therapeutics, by Disease Area, Through 2023
Table 15 : FDA Approved Estrogen-only Medicines
Table 16 : FDA Approved Progestin-only Medicines
Table 17 : FDA Approved Combination, Estrogen and Progestin Medicines
Table 18 : FDA Approved Combination Estrogen and Hormone Medicines
Table 19 : Vagifem (10mcg), Patent Expiration
Table 20 : Global Menopause Market, by Region, Through 2023
Table 21 : Prolia/XGEVA (Denosumab) Patent Expiration
Table 22 : Global Postmenopausal Osteoporosis Market, by Region, Through 2023
Table 23 : Global Endometriosis Market, by Region, Through 2023
Table 24 : Global Polycystic Ovary Syndrome Market, by Region, Through 2023
Table 25 : Global Pregnancy Disorders and Management Market, by Region, Through 2023
Table 26 : Global Womens Health Therapeutics Others Market, by Region, Through 2023
Table 27 : Global Womens Health Therapeutics, by Region, Through 2023
Table 28 : North American Market for Womens Health Therapeutics, by Disease Area Through 2023
Table 29 : European Market for Womens Health Therapeutics, by Disease Area, Through 2023
Table 30 : Asia Pacific Market for Womens Health Therapeutics, by Disease Area, Through 2023
Table 31 : South America Market for Womens Health Therapeutics, by Disease Area, Through 2023
Table 32 : Middle East and Africa Market for Womens Health Therapeutics, by Disease Area, Through 2023
Table 33 : Company Share Analysis, by Indication, 2017
Table 34 : Tier III Companies
Table 35 : Patent Review
Table 36 : Marketed Products, Postmenopausal Osteoporosis
Table 37 : AbbVie Inc., Marketed Products
Table 38 : AbbVie Inc., Net Revenue, 2015-2017
Table 39 : Allergan Plc., Marketed Products
Table 40 : Allergan Plc., Net Revenue, 2015-2017
Table 41 : Amgen Inc., Marketed Products, 2016
Table 42 : Amgen Inc.: Net Revenue, 2015-2017
Table 43 : Bayer AG, Marketed Products
Table 44 : Bayer AG, Net Revenue, 2015-2017
Table 45 : Daiichi Sankyo Company. Ltd., Marketed Products
Table 46 : Daiichi Sankyo Company Ltd. Net Revenue 2015-2017
Table 47 : Eli Lilly and Company, Marketed Products
Table 48 : Eli Lilly and Company Net Revenue, 2015-2017
Table 49 : Johnson & Johnson Inc., Marketed Products, 2016
Table 50 : Johnson & Johnson Inc. Net Revenue, 2014-2016
Table 51 : Merck & Co. Inc. Marketed Products
Table 52 : Merck & Co. Inc. Net Revenue, 2014-2016
Table 53 : Merck KGaA Marketed Products
Table 54 : Novo Nordisk, Marketed Products
Table 55 : Novo Nordisk, Net Revenue, 2015-2017
Table 56 : Pfizer Inc. Marketed Products by Indication, 2016
Table 57 : Pfizer Inc. Net Revenue, 2014-2016
Table 58 : Glossary of Terms Used in Womens Health Therapeutics
Table 59 : Abbreviations Used in Womens Health Therapeutics

List of Chart

List of Figures
Summary Figure : Global Market for Womens Health Therapeutics, by Disease Area, 2017-2023
Figure 1 : Older Population Distribution, by Age Group and Sex, 2017
Figure 2 : Older Population Distribution, by Age Group and Sex, 2050
Figure 3 : Funding for Research, Disease Condition/Category, 2014-2016
Figure 4 : Funding for Research, Womens Health, 2014-2016
Figure 5 : Insurance Coverage in the U.S., by Healthcare Providers, 2014
Figure 6 : Global Women's Health Therapeutics Market, 2017-2023
Figure 7 : Global Women's Health Therapeutics Market Share, by Disease Area, 2018
Figure 8 : Global Women's Health Therapeutics Market Share, by Disease Area, 2023
Figure 9 : Global Menopause Market, 2017-2023
Figure 10 : Global Menopause Market, by Region, 2017-2023
Figure 11 : Australia Rate of Hospitalization for Osteoporosis, People Aged 50 and Over, 2015-2016
Figure 12 : Global Postmenopausal Osteoporosis Market, 2017-2023
Figure 13 : Global Postmenopausal Osteoporosis Market, by Region, 2017-2023
Figure 14 : Global Endometriosis Market, 2017-2023
Figure 15 : Global Endometriosis Market, by Region, 2017-2023
Figure 16 : Global Polycystic Ovary Syndrome Market, 2017-2023
Figure 17 : Global Polycystic Ovary Syndrome Market, by Region, 2017-2023
Figure 18 : Global Pregnancy Disorders and Management Market, 2017-2023
Figure 19 : Global Pregnancy Disorders and Management Market, by Region, 2017-2023
Figure 20 : Global Womens Health Therapeutics Market for Others, 2017-2023
Figure 21 : Global Womens Health Therapeutics Others Market, 2017-2023
Figure 22 : Global Womens Health Therapeutics Market, by Region, 2017-2023
Figure 23 : North America Women's Health Therapeutics Market, 2017-2023
Figure 24 : North America Women's Health Therapeutics Market Share, by Disease Area, 2018
Figure 25 : North America Women's Health Therapeutics Market Share, by Disease Area, 2023
Figure 26 : North America Market for Women's Health Therapeutics, by Country, 2017-2023
Figure 27 : United States Womens Health Therapeutics Market, 2017- 2023
Figure 28 : Canada Women's Health Therapeutics Market, 2017-2023 ($ Millions)
Figure 29 : Mexico Womens Health Therapeutics Market, 2017-2023
Figure 30 : Europe Womens Health Therapeutics Market, 2017-2023
Figure 31 : Europe Women's Health Therapeutics Market Share, by Disease Area, 2018
Figure 32 : Europe Women's Health Therapeutics Market Share, by Disease Area, 2023
Figure 33 : Europe Market for Women's Health Therapeutics, by Country, 2017-2023
Figure 34 : United Kingdom Women's Health Therapeutics Market, 2017-2023
Figure 35 : Germany Women's Health Therapeutics Market, 2017-2023
Figure 36 : France Women's Health Therapeutics Market, 2017-2023
Figure 37 : Spain Women's Health Therapeutics Market, 2017-2023
Figure 38 : Italy Women's Health Therapeutics Market, 2017-2023
Figure 39 : Rest of Europe Women's Health Therapeutics Market, 2017-2023
Figure 40 : Asia-Pacific Women's Health Therapeutics Market, 2017-2023
Figure 41 : Asia-Pacific Women's Health Therapeutics Market Share, by Disease Area, 2018
Figure 42 : Asia-Pacific Women's Health Therapeutics Market Share, by Disease Area, 2023
Figure 43 : Asia Pacific Market for Women's Health Therapeutics, by Country, 2017-2023
Figure 44 : China Women's Health Therapeutics Market, 2017-2023
Figure 45 : Japan Women's Health Therapeutics Market, 2017-2023
Figure 46 : India Women's Health Therapeutics Market, 2017-2023
Figure 47 : South Korea Women's Health Therapeutics Market, 2017-2023
Figure 48 : Asia-Pacific Women's Health Therapeutics Market, 2017-2023
Figure 49 : South America Women's Health Therapeutics Market, 2017-2023
Figure 50 : South America Women's Health Therapeutics Market Share, by Disease Area, 2018
Figure 51 : South America Women's Health Therapeutics Market Share, by Disease Area, 2023
Figure 52 : Middle East & Africa Women's Health Therapeutics Market, 2017-2023
Figure 53 : Middle East & Africa Women's Health Therapeutics Market Share, by Disease Area, 2018
Figure 54 : Middle East & Africa Women's Health Therapeutics Market Share, by Disease Area, 2023
Figure 55 : Global Women's Health Therapeutics Market Share Analysis, 2017
Figure 56 : AbbVie Inc., Revenue Share, by Region, 2016
Figure 57 : Allergan PLC., Revenue Share, by Business Segment, 2016
Figure 58 : Amgen Inc. R&D Expenditure, 2014-2016
Figure 59 : Amgen Inc.: Revenue Share, by Region, 2017
Figure 60 : Bayer AG, Revenue Share, by Region, 2017
Figure 61 : Bayer AG, Revenue Share, by Business Segment, 2017
Figure 62 : Daiichi Sankyo Company. Ltd., R&D Expenditure, 2014-2016
Figure 63 : Daiichi Sankyo Company Revenue Share by Business Segment, 2016
Figure 64 : Eli Lilly and Company Revenue Share by Business Segment, 2016
Figure 65 : Eli Lilly and Company Revenue Share by Region, 2016
Figure 66 : Johnson and Johnson Inc. Revenue Share, by Business Segment, 2016
Figure 67 : Johnson and Johnson Inc. Revenue Share, by Region, 2016
Figure 68 : Merck & Co. Inc. Revenue Share by Business Segment, 2016
Figure 69 : Merck & Co. Inc. Revenue Share by Region, 2016
Figure 70 : Novo Nordisk, Revenue Share, by Region, 2016
Figure 71 : Novo Nordisk, Revenue Share, by Business Segment, 2016
Figure 72 : Pfizer Inc. Revenue Share, by Region, 2016
Figure 73 : Pfizer Inc. Revenue Share, by Business Segment, 2016

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *